CHAPTER TWO

2.0 LITERATURE REVIEW

2.1 The Family Asteraceae

The family Asteraceae, historically and alternatively referred to as Compositae, stands as one of the
most evolutionarily advanced, taxonomically complex, and ecologically successful families of flowering
plants within the order Asterales. Comprising approximately 1,620 genera and over 23,000 accepted
species, it is arguably the largest family of angiosperms in terms of species diversity, surpassing even the
Orchidaceae in certain taxonomic classifications and ecological dominance (Stevens, 2001). The family is
cosmopolitan in distribution, found on every continent except Antarctica, with significant centers of
diversity in arid and semi-arid regions, particularly in the Mediterranean basin, South Africa, South
America, and Western North America. This widespread distribution suggests a high degree of
adaptability to various ecological niches, ranging from coastal marshes to high-altitude alpine zones, and
from tropical rainforests to temperate grasslands. The ecological success of Asteraceae is often
attributed to their unique reproductive structures, efficient dispersal mechanisms, and sophisticated
chemical defense systems which deter herbivory and protect against pathogenic attacks. In the context
of medicinal chemistry and ethnopharmacology, the Asteraceae family is of paramount importance due
to the vast array of secondary metabolites produced by its members, many of which possess significant
pharmacological activities including antimicrobial, anti-inflammatory, cytotoxic, and antimalarial
properties. The chemical diversity within this family provides an unparalleled resource for drug
discovery, particularly in the search for new antimicrobial agents to combat resistant pathogens like
Escherichia coli. The resistance of many Asteraceae species to fungal and bacterial infections in the wild
suggests the presence of robust antimicrobial defense systems encoded in their secondary metabolism.
This natural defense mechanism is what researchers aim to harness for the development of new
antibiotics to treat human infections caused by resistant strains of E. coli. Morphologically, the family is
characterized by its distinctive inflorescence, the capitulum or head, which mimics a single flower but is
actually a dense aggregation of many small individual flowers known as florets arranged on a common
receptacle (Heywood et al., 2007). This composite structure is typically surrounded by an involucre of
bracts that protect the developing florets. The florets themselves are usually of two types: ray florets,
which are often zygomorphic and sterile or female, and disc florets, which are actinomorphic and
bisexual. This morphological adaptation enhances pollination efficiency by presenting a large visual
target for pollinators while minimizing the energy cost of producing large individual petals. The fruit of
Asteraceae is a cypsela, often crowned with a pappus that aids in wind dispersal, further contributing to
the family's successful colonization of diverse habitats. Understanding the morphological characteristics
of the family is essential for the correct identification of medicinal species such as Vernonia amygdalina,
as misidentification can lead to the use of ineffective or toxic plant materials in traditional medicine.

The taxonomic history of the family has undergone significant revision with the advent of molecular
phylogenetics, leading to a better understanding of the relationships between tribes and genera. The
tribe Vernonieae, to which Vernonia belongs, is characterized by predominantly purple or blue flowers
and style branches that are rounded or truncate without a distinct appendage, distinguishing them from
other tribes within the Asteraceae. This tribal classification is crucial for predicting chemical profiles, as
closely related tribes often share similar secondary metabolite pathways. Chemically, the Asteraceae
family is renowned for producing an extensive array of secondary metabolites that serve as taxonomic
markers and defense mechanisms. The chemical diversity within this family is unmatched by most other
plant families, making it a rich resource for phytochemical investigation and drug discovery.

Asteroideae, Cichorioideae, Carduoideae, and others, based on morphological characteristics and

chemical profiles. The genus Vernonia belongs to the subfamily Asteroideae and the tribe Vernonieae.
Plants in this family have a long and documented history of use in traditional medicine across various
cultures globally. For instance, Artemisia annua, a member of this family, is the source of artemisinin, a
potent antimalarial drug that revolutionized the treatment of Plasmodium falciparum malaria. Similarly,
Matricaria chamomilla is widely used for its soothing, anti-inflammatory, and antispasmodic properties
(WHO, 2009). Phytochemical investigations of Asteraceae species have revealed the presence of
alkylamides, coumarins, phenolic acids, and lignans, which contribute to their medicinal value. The
presence of these compounds varies significantly between genera and even between species within the
same genus, influenced by environmental factors such as soil type, climate, altitude, and seasonal
variations (Harborne, 1998). This chemical variability necessitates detailed phytochemical screening of
specific species to validate their traditional uses and identify active constituents. The economic
importance of the family extends beyond medicine to include ornamental plants, food crops (such as
lettuce and sunflower), and industrial products (such as natural rubber from Taraxacum kok-saghyz ).
The taxonomic classification of the family has been subject to revision based on molecular data. The
Angiosperm Phylogeny Group (APG) system places Asteraceae in the order Asterales, within the
campanulid clade of the eudicots. This classification is supported by morphological synapomorphies
such as the inferior ovary, syngenesious stamens, and the presence of inulin as a storage carbohydrate.
The tribe Vernonieae, containing Vernonia, is characterized by predominantly paleate receptacles and
style branches with sweeping hairs. The genus Vernonia itself has undergone significant taxonomic
revision, with many New World species being moved to the genus Vernonia sensu stricto, while Old
World species remain in Vernonia or are moved to related genera such as Gymnanthemum. Vernonia
amygdalina remains firmly placed within the Old World Vernonia group. Understanding these taxonomic
nuances is critical for literature review accuracy, as chemical profiles can differ between the New World
and Old World groups. In the context of this study, the family Asteraceae provides the taxonomic
framework for understanding the chemical potential of Vernonia amygdalina.

2.2 The Genus Vernonia

The genus Vernonia is a large and taxonomically significant group within the family Asteraceae,
consisting of approximately 1,000 species distributed primarily in tropical and subtropical regions, with a
high concentration in Africa and the Americas (Robinson & Skvarla, 2009). The genus is named after
William Vernon, an English botanist who collected plants in Maryland in the late 17th century. Species of
Vernonia are predominantly shrubs or herbs, though some grow as small trees, and they are
characterized by their purple or pink flower heads and alternate leaves. In Africa, the genus is well-
represented, with many species used in traditional medicine for the treatment of various ailments
ranging from fever and malaria to gastrointestinal disorders and skin infections (Iwu, 2010).
In Nigeria, several species of Vernonia are recognized, including Vernonia amygdalina, Vernonia

colorata, and Vernonia cinerea, each with distinct ethnobotanical profiles. Vernonia amygdalina is

perhaps the most widely studied and utilized species within the genus due to its dual role as a food

vegetable and a medicinal plant (Maroyi, 2017). The genus exhibits significant morphological variability,

which has historically led to taxonomic confusion, but modern molecular phylogenetic studies have

helped clarify the relationships between species. The correct identification of species within this genus is

critical, as chemical profiles can vary significantly even between closely related species, affecting the

efficacy of the medicinal preparations derived from them. Recent taxonomic revisions have moved many

New World species to the genus Vernonia sensu stricto, while Old World species remain in Vernonia or

are moved to related genera such as Gymnanthemum. Vernonia amygdalina remains firmly placed

within the Old World Vernonia group (Funk et al., 2009). Understanding these taxonomic nuances is

critical for literature review accuracy, as chemical profiles can differ between the New World and Old

World groups. Chemical systematics within the genus Vernonia has led to the isolation of various

secondary metabolites, including sesquiterpene lactones, flavonoids, alkaloids, and terpenoids (Erasto et

al., 2006). The distribution of these metabolites varies among species, providing insights into the

phylogenetic relationships within the genus. For example, Vernonia amygdalina is rich in vernolide and

vernodaline, while Vernonia colorata contains different profiles of sesquiterpene lactones. Bioactivity

studies on Vernonia species conducted between 2006 and 2025 have demonstrated a wide range of

pharmacological properties. Extracts from various species have shown significant antimicrobial activity

against bacteria such as Staphylococcus aureus, Bacillus subtilis, and Escherichia coli (Nwinyi et al.,

2009). The antimicrobial activity is often attributed to the presence of sesquiterpene lactones,

flavonoids, and alkaloids. Additionally, some Vernonia species exhibit antiplasmodial activity,

making them valuable in the treatment of malaria. Vernonia amygdalina, in particular, has been

extensively studied for its antidiabetic, anticancer, and antimicrobial properties (Atangwho et al.,

2009). The bitter principles isolated from Vernonia species have been shown to inhibit the

growth of various pathogens, supporting their traditional use in treating infectious diseases. The
bioactivity of Vernonia extracts is often linked to the synergistic effects of multiple

phytochemicals rather than a single compound. This synergy can enhance the efficacy of the

extract against pathogens and reduce the likelihood of resistance development. However, the

specific contribution of individual compounds to the overall activity requires isolation and

structural elucidation. Previous studies on Vernonia species have isolated compounds such as

vernomygdin, vernolide, and hydroxyvernolide, which have shown potent biological activities

(Ohigashi et al., 2010). Understanding the chemical systematics of the genus helps in selecting

species with high potential for drug development and conservation efforts. The genus Vernonia

also contains compounds with insecticidal properties, which are used in traditional agriculture to

protect stored grains from pests. This dual utility as both medicine and pesticide highlights the

economic importance of the genus in developing countries (Giday et al., 2010).

2.3 Vernonia Amygdalina

Vernonia amygdalina Delile, commonly known as bitter leaf, is a shrub or small tree that grows

widely in tropical Africa. It is one of the most popular medicinal plants in Africa, particularly in

Nigeria, Kenya, and Uganda, where it is used both as a vegetable and a medicine. The plant is

known for its bitter taste, which is attributed to the presence of sesquiterpene lactones and

glycosides. The leaves are the most commonly used part, although the roots and stem bark are

also utilized in traditional remedies (Iwu, 2010). The plant's popularity stems from its

accessibility, ease of cultivation, and broad spectrum of therapeutic applications recognized by

indigenous communities. In the context of this study, Vernonia amygdalina is selected due to its

widespread use in treating gastrointestinal infections, which are often caused by E. coli, and the

need to scientifically validate these claims through phytochemical and antimicrobial analysis.

2.3.1 Botanical Description of Vernonia Amygdalina

Vernonia amygdalina belongs to the family Asteraceae and is characterized by its rough, greyish

bark and green leaves with serrated margins. The leaves are elliptic to lanceolate in shape,

arranged alternately on the stem, and have a distinct bitter taste. The plant produces small, white

or pale purple flower heads arranged in clusters at the ends of branches. The fruits are small

achene with pappus, typical of the Asteraceae family (Burkill, 2015). The plant thrives in humid

tropical climates and is often found in disturbed areas, forest margins, and along riverbanks. It

can grow up to 5 meters in height and is relatively easy to cultivate, making it accessible to rural

communities. The botanical identity of the plant is crucial for ensuring the consistency of

phytochemical and pharmacological studies. Misidentification of plant materials can lead to

erroneous results and compromise the validity of scientific findings. Therefore, authentication by

a taxonomist and deposition of voucher specimens in a recognized herbarium are standard

practices in phytochemical research (Harborne, 2018). The plant's morphology can vary slightly

depending on the ecological zone, with plants in drier regions often exhibiting smaller leaves and

thicker bark compared to those in humid regions. The root system is fibrous and shallow,

allowing the plant to recover quickly after pruning, which is a common practice when harvesting

leaves for consumption or medicinal use. The flowering season typically occurs during the rainy

season, and seed production is viable, allowing for propagation through both seeds and stem

cuttings. Understanding the botanical features ensures that the correct plant material is used for

extraction, which is vital for reproducibility in scientific research. The leaves are typically

harvested when mature but still tender, as this is when the concentration of active

phytochemicals is believed to be optimal. The stem bark is woody and furrowed, providing

structural support and storing secondary metabolites that may differ from those in the leaves. The

flowers are insect-pollinated, and the seeds are dispersed by wind, facilitating the plant's spread

across suitable habitats. The plant's ability to regenerate after harvesting makes it a sustainable

source of medicinal material if managed correctly (Maroyi, 2017).

2.3.2 Medicinal Uses of Vernonia Amygdalina

In traditional Nigerian medicine, Vernonia amygdalina is used to treat a wide variety of ailments.

The leaves are commonly chewed or brewed as a decoction to treat malaria, fever, and

gastrointestinal disorders such as diarrhea and dysentery (Kokwaro, 2010). The bitter juice

extracted from the leaves is believed to cleanse the blood and boost the immune system. In

Nigeria, various ethnic groups including the Hausa, Yoruba, and Igbo communities use the plant

extracts to treat stomach ache and intestinal worms (Geissler et al., 2010). The plant is also used

in the management of diabetes mellitus. Studies have shown that aqueous extracts of Vernonia

amygdalina leaves can lower blood glucose levels in alloxan-induced diabetic rats (Atangwho et

al., 2009). This hypoglycemic effect is attributed to the presence of phytochemicals that may

enhance insulin secretion or improve insulin sensitivity. Additionally, the plant is used topically

to treat skin infections, wounds, and ringworm. The antimicrobial properties of the plant support

its use in treating infectious diseases, although scientific validation of these claims against

specific pathogens like E. coli is necessary. In some cultures, the root bark is used to treat

venereal diseases and as a contraceptive. The stem bark is chewed to relieve toothache and sore

throat. The versatility of Vernonia amygdalina in traditional medicine highlights its potential as a

source of new therapeutic agents. However, the lack of standardized dosage and safety data

poses risks to users. Scientific investigation into the efficacy and toxicity of the plant is essential

to ensure its safe use and integration into modern healthcare systems (WHO, 2021). The plant is

also used to treat respiratory conditions such as coughs and bronchitis, often in combination with

other herbs like ginger or garlic. In maternal health, extracts are sometimes used to facilitate

childbirth or treat postpartum infections, although these uses require careful toxicological

evaluation due to potential uterine stimulant effects. The specific focus of this study on E. coli is

driven by the plant's traditional use in treating diarrhea, a condition frequently caused by

enterotoxigenic E. coli strains. The plant's reputation as a "cure-all" in some communities

underscores the need for rigorous scientific scrutiny to separate fact from folklore (Ekor, 2014).

Recent ethnobotanical surveys conducted in 2020 confirm that Vernonia amygdalina remains
one of the top five medicinal plants used for gastrointestinal disorders in West Africa

(Ogbunugafor et al., 2020).

2.3.3 Other Uses of Vernonia Amygdalina

Apart from its medicinal value, Vernonia amygdalina has several other uses. The leaves are

consumed as a vegetable in soups and stews, particularly in Nigeria. The bitterness is often

reduced by washing or squeezing the leaves before cooking. The plant is also used as fodder for

livestock, although excessive consumption can be toxic due to the presence of secondary

metabolites (Burkill, 2015). This application is particularly relevant in Northern Nigeria, where

livestock rearing is a major economic activity. The plant has agricultural applications as well.

Extracts from the leaves have been shown to possess insecticidal properties, making them useful

in pest control. Farmers use the plant to protect stored grains from weevils and other pests.

Additionally, Vernonia amygdalina is used in soil conservation and as a hedge plant due to its

rapid growth and hardiness. The wood is sometimes used for fuel and construction of simple

structures. These diverse uses underscore the importance of the plant in the socio-economic lives

of rural communities. The plant's ability to grow in degraded soils makes it useful for land

reclamation projects. Furthermore, the essential oils extracted from the leaves have potential

applications in the fragrance and flavor industries, although this remains largely underexploited

commercially. The multifaceted utility of the plant reinforces the need for comprehensive

scientific study to maximize its benefits while mitigating potential risks associated with its use.

The plant's role in food security is significant, as it provides essential vitamins and minerals

alongside its medicinal properties. The integration of Vernonia amygdalina into agroforestry

systems could provide both economic and ecological benefits to farming communities (Giday et

al., 2010).

2.3.4 Phytochemicals in Vernonia amygdalina

The phytochemical profile of Vernonia amygdalina is exceptionally diverse, reflecting its

evolutionary adaptation as a defensive mechanism against herbivores, pathogens, and

environmental stressors. Extensive phytochemical investigations conducted over the past

several decades have identified a wide array of secondary metabolites belonging to various

chemical classes, including sesquiterpene lactones, flavonoids, alkaloids, saponins, tannins,

glycosides, and sterols. The concentration and distribution of these phytochemicals vary

significantly depending on the plant part utilized, with the leaves containing the highest

concentration of bioactive constituents compared to the stem bark or roots. This variation

is influenced by factors such as the age of the plant, seasonal variations, soil composition,

and geographical location, necessitating standardized collection and processing protocols

for scientific studies. The leaves, which are the primary focus of this study, are particularly

rich in bitter principles, which are predominantly sesquiterpene lactones and steroidal

glycosides. The sesquiterpene lactones constitute the most significant class of bioactive

compounds in Vernonia amygdalina, responsible for the characteristic bitter taste and a

substantial portion of its pharmacological activities. Prominent sesquiterpene lactones

isolated from the leaves include vernolide, vernodaline, hydroxyvernolide, vernomygdin,

and vernolepin. These compounds possess a common structural feature known as the α-

methylene-γ-lactone moiety, which is highly reactive and capable of alkylating biological

nucleophiles such as sulfhydryl groups in enzymes and proteins. This alkylation

mechanism is crucial for their antimicrobial activity, as it can inhibit essential bacterial

enzymes involved in cell wall synthesis, DNA replication, and metabolic pathways.

Vernolide and vernodaline, in particular, have demonstrated potent cytotoxic and

antimicrobial properties in various in vitro studies. The structural complexity of these

lactones, often featuring multiple chiral centers and oxygenated functional groups,

contributes to their specific biological interactions and selectivity against different

microbial strains. The isolation of these compounds typically requires non-polar to

moderately polar solvents such as dichloromethane or ethyl acetate, reflecting their

lipophilic nature. Flavonoids represent another major class of phytochemicals found in

Vernonia amygdalina, contributing significantly to its antioxidant and antimicrobial

potential. Identified flavonoids include luteolin, apigenin, quercetin, and their glycosidic

derivatives, as well as flavan-3-ols such as epicatechin. These compounds possess a

characteristic C6-C3-C6 skeleton consisting of two aromatic rings connected by a three-

carbon bridge. The hydroxyl groups on the aromatic rings are critical for their biological

activity, enabling them to act as hydrogen donors in antioxidant reactions and to form

complexes with bacterial cell wall components. Epicatechin, a flavan-3-ol, has been

specifically isolated from Vernonia amygdalina and has shown significant antibacterial

activity against Gram-positive and Gram-negative bacteria. The mechanism of action for

flavonoids often involves the disruption of bacterial cell membranes, inhibition of nucleic

acid synthesis, and interference with energy metabolism. The presence of these compounds

is often detected in polar extracts such as methanol or ethyl acetate, and their identification

relies heavily on spectroscopic techniques such as UV-Visible spectroscopy, Nuclear

Magnetic Resonance (NMR), and Mass Spectrometry (MS).

Alkaloids, although present in lower concentrations compared to sesquiterpene lactones

and flavonoids, contribute to the pharmacological profile of Vernonia amygdalina.

Compounds such as vernodalin and vernomygdin have been identified and characterized.

Alkaloids are nitrogen-containing organic compounds that often exhibit potent

physiological effects on living systems. In the context of antimicrobial activity, alkaloids can

intercalate into bacterial DNA, inhibit enzyme function, or disrupt cell membrane

integrity. The basic nature of alkaloids allows them to form salts with acids, which

influences their solubility and extraction behavior. In Vernonia amygdalina, alkaloids are

often extracted using acidified solvents followed by basification and partitioning into
organic solvents. The presence of alkaloids adds to the synergistic effect of the crude

extract, where multiple compounds work together to enhance the overall antibacterial

efficacy. The toxicity of some alkaloids necessitates careful evaluation of the safety profile

of Vernonia amygdalina extracts, although traditional usage suggests a wide margin of

safety when consumed in dietary amounts. Saponins are glycosidic compounds

characterized by their ability to form foam in aqueous solutions due to their amphipathic

nature, possessing both hydrophobic (aglycone) and hydrophilic (sugar) moieties. In

Vernonia amygdalina, saponins contribute to the bitter taste and have been implicated in

the plant's antimicrobial and immunomodulatory activities. The aglycone portion, or

sapogenin, can be steroidal or triterpenoid in nature. The mechanism of antimicrobial

action for saponins involves the interaction with the sterol components of microbial cell

membranes, leading to pore formation, leakage of cellular contents, and eventual cell lysis.

This mechanism is particularly effective against fungi and Gram-positive bacteria, but

some saponins have also shown activity against Gram-negative bacteria like E. coli by

disrupting the outer membrane. The hemolytic activity of saponins is a concern for

systemic use, but their topical or oral application in traditional medicine has been practiced

safely for centuries. The extraction of saponins typically involves polar solvents such as

methanol or water, and their detection is often confirmed by foam tests and specific color

reactions with reagents like Liebermann-Burchard. Tannins are high-molecular-weight

polyphenolic compounds that are widely distributed in the plant kingdom and are present

in Vernonia amygdalina. They are classified into hydrolyzable tannins (gallotannins and

ellagitannins) and condensed tannins (proanthocyanidins). Tannins are known for their

ability to bind and precipitate proteins, which forms the basis of their antimicrobial

mechanism. By binding to bacterial enzymes and cell wall proteins, tannins can inhibit

microbial growth and reduce virulence. In the context of gastrointestinal infections caused

by E. coli, tannins can also bind to toxins and reduce their absorption, providing a

therapeutic benefit. The astringent property of tannins is utilized in traditional medicine to

treat diarrhea and wounds. The presence of tannins in Vernonia amygdalina is confirmed

by positive reactions with ferric chloride (producing a blue-black color) and gelatin

solutions (producing a precipitate). The concentration of tannins can vary based on the

maturity of the leaves, with younger leaves often containing higher levels of condensed

tannins. Sterols and terpenoids are also significant constituents of Vernonia amygdalina.

Lupeol and β-sitosterol are two prominent triterpenoid and phytosterol compounds,

respectively, that have been isolated from the plant. Lupeol is a pentacyclic triterpene

known for its anti-inflammatory, antimicrobial, and anticancer properties. β-Sitosterol is a

plant sterol structurally similar to cholesterol, known for its ability to lower cholesterol

levels and its immunomodulatory effects. Both compounds are lipophilic and are typically

found in non-polar extracts such as hexane or dichloromethane. Their antimicrobial

activity is often attributed to their ability to integrate into bacterial cell membranes,

altering fluidity and permeability. The presence of these compounds adds to the

therapeutic versatility of Vernonia amygdalina, making it effective against a broad

spectrum of ailments beyond infectious diseases. The structural elucidation of these

compounds relies on detailed NMR analysis, particularly 13C-NMR and DEPT

experiments, to distinguish between the various carbon types in the complex terpenoid

skeletons.

2.3.5 Importance of Phytochemicals

The study of phytochemicals in medicinal plants like Vernonia amygdalina is of paramount

importance in the current global health landscape, characterized by the rising prevalence

of antimicrobial resistance and the high cost of synthetic pharmaceuticals. Phytochemicals

represent a vast reservoir of chemical diversity that has been optimized by evolution for

biological activity. Unlike synthetic drugs which often target a single specific pathway,

phytochemicals in crude extracts often act through multiple mechanisms simultaneously,

reducing the likelihood of resistance development. This multi-target activity is particularly

relevant in the treatment of infections caused by resilient pathogens like Escherichia coli,

which possess sophisticated mechanisms to evade single-mode antibiotics. The importance

of phytochemicals lies not only in their direct antimicrobial effects but also in their ability

to modulate the host immune system, reduce inflammation, and provide antioxidant

protection against tissue damage caused by infection.

Furthermore, phytochemicals serve as lead compounds for the development of new drugs.

Many modern pharmaceuticals are derived from or inspired by plant secondary

metabolites. For instance, the sesquiterpene lactones found in Vernonia amygdalina share

structural similarities with other clinically used antimicrobial and anticancer agents. By

isolating and characterizing these compounds, researchers can modify their structures to

enhance potency, reduce toxicity, and improve pharmacokinetic properties. This process of

drug discovery from natural products is known as pharmacognosy, and it remains a vital

strategy in the search for new therapeutic agents. The economic importance of

phytochemicals also extends to the potential for local production of medicines in developing

countries, reducing dependence on imported drugs and fostering sustainable healthcare

systems. In Nigeria, where Vernonia amygdalina is widely available and culturally

significant, harnessing its phytochemical potential could provide affordable treatment

options for rural communities, particularly in Northern Nigeria where access to

conventional antibiotics may be limited. Safety and toxicity are critical aspects of

phytochemical research. While natural products are often perceived as safe, they can

possess potent biological activities that may be harmful at high doses or in specific

populations. Detailed phytochemical analysis allows for the identification of potentially

toxic compounds, such as certain alkaloids or high concentrations of saponins, enabling the

establishment of safe dosage guidelines. Toxicological studies alongside phytochemical

screening ensure that the traditional use of Vernonia amygdalina is validated scientifically
and that any risks are mitigated. The standardization of herbal preparations based on their

phytochemical content is essential for consistency in therapeutic effects. Without

standardization, the efficacy of herbal medicines can vary widely between batches, leading

to unreliable treatment outcomes. Therefore, the quantification of marker compounds such

as vernolide or epicatechin is crucial for quality control in the production of Vernonia

amygdalina-based medicines. The conservation of medicinal plants is another important

implication of phytochemical research. As the demand for herbal medicines grows, there is

a risk of over-harvesting wild populations of plants like Vernonia amygdalina. Scientific

validation of their efficacy can promote sustainable cultivation practices and ensure the

long-term availability of these resources. Furthermore, understanding the chemical basis of

their activity can lead to the development of synthetic analogs, reducing the pressure on

wild plant populations. The integration of traditional knowledge with modern scientific

methods creates a synergistic approach to healthcare that respects cultural heritage while

ensuring safety and efficacy. In the context of E. coli infections, which are a major cause of

morbidity in developing countries including Nigeria, the development of phytochemical-

based treatments could significantly reduce the burden of disease. The importance of

phytochemicals thus extends beyond chemistry and biology to encompass public health,

economics, and conservation.

2.4 Antimicrobial Assays

Antimicrobial assays are used to evaluate the effectiveness of substances against

microorganisms. The two principal methods of determining antimicrobial activity in vitro

are diffusion and dilution methods. The diffusion method involves the use of a filter paper

disc, a porous cup, or a bottomless cylinder containing measured quantities of drug, which

is placed on a solid medium in a petri dish. In the agar well diffusion method, wells are cut

into the agar medium, and the test substance is introduced into the wells. After incubation,
the diameter of the clear zone of inhibition surrounding the deposit of drug is taken as a

measure of the inhibitory power of the drug against the particular test organism. The size

of the zone is proportional to the activity of the substance, although this relationship is not

always linear due to differences in diffusion rates of different compounds. The agar well

diffusion method is preferred in this study for its ability to accommodate liquid extracts

and its sensitivity in detecting activity against specific isolates like E. coli. It allows for the

testing of crude extracts which may not impregnate filter paper discs evenly. Dilution

methods are employed when determining the Minimum Inhibitory Concentration (MIC) of

drugs. This is the smallest amount of the drug that inhibits the multiplication of the

pathogen. MIC is usually determined by a broth dilution method either in test tubes or in

panels of small wells. A standard inoculum of the pathogen is incubated in a series of tubes

or wells containing decreasing concentrations of the drugs or samples being tested. If the

drug inhibits the microbe at the concentration in the tube, no growth appears. The

organism grows only in concentrations below the one required for inhibition. Therefore,

the highest dilution (lowest concentration) showing no visible growth is the MIC. The

Minimum Bactericidal Concentration (MBC) is determined by sub-culturing from the MIC

tubes onto fresh media to see if the bacteria are killed or just inhibited. These methods

provide precise measurements of antimicrobial activity and are essential for determining

the therapeutic potential of plant extracts. For E. coli, these assays help determine whether

Vernonia amygdalina extracts are bacteriostatic or bactericidal. The choice of method

depends on the nature of the extract and the resources available. Standardization is crucial

for reproducibility, and guidelines such as those from the Clinical and Laboratory

Standards Institute (CLSI) are followed to ensure consistency.

2.5 Flavonoids

Flavonoids and their conjugates form a very large group of natural products found in

many plant tissues, where they are present inside cells or on the surfaces of different plant
organs. They are primarily 15-carbon skeleton compounds composed of two benzene rings

that are usually phenolic and connected by a 3-carbon unit. The chemical structures of this

class of compounds are therefore based on a C6-C3-C6 skeleton. Different substituents can

occur on the basic skeleton and thereby contribute to the diversity of flavonoids. The A-

ring is characteristically of the phloroglucinol or resorcinol hydroxylation pattern, while

the B-ring is usually 4-, 3,4-, or 3,4,5-hydroxylated but may occur unsubstituted. The

arrangement and oxidation level of the central three-carbon portion brings about the main

classification of flavonoids. Flavans, flavones, flavanones, isoflavones, and anthocyanidines

have a pyran ring, while aurones have a furan ring. In chalcones, the hydroxyl group

persists but may be derivatized. Flavonols and flavononols, which form classes of their

own, are the oxidized forms of flavones and flavanones, respectively. In Vernonia

amygdalina, flavonoids such as epicatechin contribute significantly to the antioxidant and

antimicrobial properties.

2.6 Alkaloids

Alkaloids are nitrogen-containing organic compounds that are primarily found in plants

and are known for their potent physiological effects on humans and animals. Examples

include morphine, quinine, and caffeine. In Vernonia amygdalina, alkaloids such as

vernodalin and vernomygdin have been identified. These compounds are believed to

contribute to the bitter taste and medicinal properties of the plant. Alkaloids are classified

based on their chemical structure and biosynthetic origin. Common classes include indole

alkaloids, isoquinoline alkaloids, and tropane alkaloids. The biosynthesis of alkaloids

typically involves amino acids such as tyrosine, tryptophan, or ornithine as precursors. The

nitrogen atom is usually derived from the amino acid. Alkaloids often act as defense

compounds against herbivores due to their toxicity. In medicine, they are used as

analgesics, antimalarials, and stimulants. The structural diversity of alkaloids is vast,

ranging from simple amines to complex polycyclic structures. This diversity contributes to
their wide range of biological activities. The antimicrobial activity of alkaloids is attributed

to their ability to intercalate into DNA, inhibit enzyme function, or disrupt cell membranes.

Some alkaloids have shown activity against Gram-negative bacteria like E. coli. However,

their toxicity limits their therapeutic use. In Vernonia amygdalina, the concentration of

alkaloids is relatively low compared to sesquiterpene lactones, but they may play a

synergistic role in the overall bioactivity of the plant extracts. The basic nature of alkaloids

allows them to form salts with acids, which affects their solubility and extraction. Acid-base

extraction is commonly used to isolate alkaloids from plant materials. The study of

alkaloids in Vernonia amygdalina is important for understanding the plant's toxicity

profile and therapeutic potential. Their presence contributes to the overall

pharmacological profile that makes the plant effective against bacterial infections. The

isolation of alkaloids requires careful pH control during extraction to ensure they remain

in their free base or salt form as needed for separation.

2.7 Saponins

Saponins are glycosides characterized by their ability to form foam in aqueous solutions.

They consist of a hydrophobic aglycone (sapogenin) attached to one or more hydrophilic

sugar moieties. Saponins are classified into steroidal and triterpenoid saponins based on

the structure of the aglycone. They are widely distributed in plants and are known for their

hemolytic, antimicrobial, and immunomodulatory properties. In Vernonia amygdalina,

saponins contribute to the plant's bitter taste and medicinal value. They have been shown

to exhibit antimicrobial activity by disrupting the cell membranes of microorganisms. The

hydrophobic part of the saponin interacts with the lipid bilayer, while the hydrophilic part

interacts with the aqueous environment, leading to pore formation and cell lysis. This

mechanism is effective against both Gram-positive and Gram-negative bacteria. The

amphipathic nature of saponins makes them unique among phytochemicals, allowing them

to interact with both lipid and aqueous phases in biological systems. Saponins also have
adjuvant properties, enhancing the immune response to vaccines. However, their hemolytic

activity can be toxic if consumed in large quantities. In traditional medicine, saponin-

containing plants are often processed to reduce toxicity. The presence of saponins in

Vernonia amygdalina supports its use in treating infections, although further studies are

needed to determine the specific saponins responsible for the activity against E. coli. The

stability of saponins during extraction is influenced by pH and temperature. Acidic

conditions can hydrolyze the glycosidic bond, releasing the sapogenin. This hydrolysis can

alter the biological activity of the compound. Saponins are also known to lower cholesterol

levels by binding to bile acids in the intestine. This property adds to the therapeutic

potential of Vernonia amygdalina in managing metabolic disorders. The foaming property

of saponins is used in quality control tests to detect their presence in extracts. The

structural elucidation of saponins is complex due to the sugar moieties, often requiring

enzymatic hydrolysis to analyze the aglycone separately.

2.8 Tannins

Tannins are high-molecular-weight polyphenolic compounds that bind to proteins and

other macromolecules. They are classified into hydrolyzable tannins (gallotannins and

ellagitannins) and condensed tannins (proanthocyanidins). Tannins are found in many

plants, including tea, wine, and medicinal herbs. They are known for their astringent taste

and antioxidant properties. In Vernonia amygdalina, tannins contribute to the plant's

ability to treat diarrhea and wounds. They act by precipitating proteins on the mucosal

surface, forming a protective layer that reduces inflammation and prevents microbial

invasion. Tannins also inhibit microbial enzymes and deprive microorganisms of substrates

required for growth. This makes them effective against gastrointestinal pathogens like E.

coli. The antimicrobial activity of tannins is concentration-dependent. At high

concentrations, they can be toxic to host cells. However, at therapeutic doses, they provide

a safe and effective means of controlling infections. The presence of tannins in Vernonia
amygdalina validates its traditional use in treating digestive disorders. Phytochemical

screening usually detects tannins using ferric chloride or gelatin tests, confirming their

presence in the extracts. Tannins also have antioxidant properties, scavenging free radicals

and preventing oxidative damage. This contributes to the plant's overall health benefits.

The interaction of tannins with proteins can interfere with digestion, which is a

consideration for their use as food additives. In leather tanning, tannins are used to convert

animal hides into leather due to their protein-binding capacity. This industrial application

highlights the chemical reactivity of tannins. In medicine, this reactivity is harnessed to

treat burns and skin ulcers by forming a protective eschar. The multifaceted role of tannins

in Vernonia amygdalina underscores their importance in the plant's defense mechanism

and medicinal utility.

2.9 Escherichia coli and Antimicrobial Resistance

Escherichia coli is a Gram-negative bacterium commonly found in the gastrointestinal tract of

humans and animals. While many strains are harmless, pathogenic variants are responsible for

infections such as urinary tract infections, diarrhoea, septicemia, and meningitis. In recent years,

Escherichia coli has become one of the most significant organisms associated with antimicrobial

resistance (AMR), posing a serious global public health concern.

Antimicrobial resistance in Escherichia coli has increased significantly due to the misuse and

overuse of antibiotics in human medicine, agriculture, and animal husbandry. The organism has

demonstrated a remarkable ability to develop resistance mechanisms, making infections

increasingly difficult to treat (Zhang et al., 2024). The adaptability of E. coli allows it to acquire

and spread resistance genes through horizontal gene transfer, thereby accelerating the

dissemination of resistance across different environments.

Several mechanisms contribute to antimicrobial resistance in Escherichia coli. These include the

production of enzymes such as β-lactamases that inactivate antibiotics, modification of antibiotic

target sites, reduced permeability of the bacterial cell membrane, and the presence of efflux

pumps that expel antimicrobial agents from the cell (Nasrollahian et al., 2024). Among these

mechanisms, the production of extended-spectrum β-lactamases (ESBLs), particularly bla_CTX-

M genes, has been widely reported and is associated with resistance to penicillins and

cephalosporins.

Recent studies conducted between 2020 and 2024 indicate a rising prevalence of multidrug-

resistant (MDR) Escherichia coli strains, especially in developing countries. In Nigeria,

increasing resistance patterns have been reported among clinical isolates, which is linked to the

widespread and often unregulated use of antibiotics (Anueyiagu et al., 2024). This trend presents

a major challenge to healthcare systems, as it limits the effectiveness of commonly used

antibiotics.

Furthermore, uropathogenic Escherichia coli (UPEC), a leading cause of urinary tract infections,

has shown high resistance rates to frequently prescribed antibiotics, complicating treatment and

increasing the risk of recurrent infections (Asmare et al., 2024). Environmental factors also play

a significant role in the spread of resistant strains, as contaminated water sources and poor

sanitation contribute to the transmission of antimicrobial-resistant E. coli (Rabiu et al., 2024).

To address antimicrobial resistance in Escherichia coli, several strategies have been

recommended. These include the implementation of antibiotic stewardship programs, continuous

surveillance of resistance patterns, public health education, and the development of alternative

therapeutic agents such as plant-based antimicrobials. Medicinal plants like Vernonia

amygdalina are increasingly being explored for their potential antibacterial properties against

resistant bacterial strains.

2.10 Role as an Indicator Organism

Escherichia coli is widely used as an indicator organism in microbiology due to its consistent presence in

the intestinal tract of humans and warm-blooded animals. Its detection in environmental samples such
as water and food is commonly used as evidence of faecal contamination and the possible presence of

pathogenic microorganisms.

As an indicator organism, Escherichia coli is particularly valuable because it is relatively easy to isolate

and identify using standard microbiological techniques. Its presence suggests recent contamination,

since the organism does not typically survive long outside the host under normal environmental

conditions. Therefore, it is frequently used in assessing the microbiological quality of drinking water,

recreational water, and food products (Zhang et al., 2024).

In recent years, Escherichia coli has also been utilized as an important indicator for monitoring

antimicrobial resistance (AMR) in both clinical and environmental settings. Due to its ability to acquire

and transfer resistance genes, E. coli serves as a sentinel organism for tracking the spread of resistance

within microbial populations (Nasrollahian et al., 2024). Surveillance studies often rely on E. coli to

provide insight into resistance trends, particularly in low- and middle-income countries where

monitoring systems may be limited.

Studies conducted between 2020 and 2024 have emphasized the importance of Escherichia coli in

environmental surveillance of antimicrobial resistance. The detection of multidrug-resistant strains in

water bodies, soil, and food sources highlights its role in indicating the dissemination of resistant

bacteria in the environment (Rabiu et al., 2024). In Nigeria, the presence of resistant E. coli in clinical

and environmental samples has been linked to poor sanitation, inadequate waste management, and

indiscriminate antibiotic use (Anueyiagu et al., 2024).

Furthermore, the use of Escherichia coli as an indicator organism extends to public health risk

assessment. Its presence in drinking water systems signals potential exposure to harmful pathogens,

thereby necessitating immediate intervention to prevent disease outbreaks. The increasing occurrence

of antibiotic-resistant E. coli strains further strengthens its importance as a dual indicator of both

contamination and antimicrobial resistance (Asmare et al., 2024).

2.11 Pathogenicity and Public Health Impact

Escherichia coli is a diverse bacterial species comprising both harmless commensal strains and

pathogenic variants capable of causing a wide range of diseases in humans. Pathogenic

Escherichia coli strains are classified into different pathotypes based on their virulence factors

and mechanisms of infection, including enteropathogenic (EPEC), enterotoxigenic (ETEC),

enterohemorrhagic (EHEC), and uropathogenic (UPEC) strains.

The pathogenicity of Escherichia coli is primarily linked to the presence of virulence factors such

as adhesins, toxins, invasins, and capsules. These enable the organism to colonize host tissues,

evade immune responses, and cause disease. For instance, shiga toxin-producing E. coli (STEC)

is associated with severe gastrointestinal infections and complications such as hemolytic uremic

syndrome (HUS), a condition that can result in acute kidney failure (Tenaillon et al., 2021).

In addition to intestinal infections, extraintestinal pathogenic Escherichia coli (ExPEC) are

responsible for infections outside the gastrointestinal tract. Uropathogenic E. coli (UPEC) is the

leading cause of urinary tract infections globally, while other strains are implicated in neonatal

meningitis and bloodstream infections (Flores-Mireles et al., 2020). These infections

significantly contribute to global morbidity and mortality, especially among high-risk

populations.

The public health impact of Escherichia coli has been further exacerbated by the rise in

antimicrobial resistance. The increasing prevalence of multidrug-resistant (MDR) strains has

made treatment more complicated and less effective, resulting in prolonged illness and increased

healthcare burden (Mancuso et al., 2021). Resistance to commonly used antibiotics, including

cephalosporins and fluoroquinolones, is now widely reported.

Recent studies (2020–2024) indicate that Escherichia coli infections remain a major public health

concern, particularly in developing countries where sanitation challenges and antibiotic misuse

are prevalent. The spread of resistant strains through contaminated food, water, and healthcare

settings has intensified the burden of disease (WHO, 2023).

Foodborne outbreaks caused by pathogenic Escherichia coli have also been reported worldwide,

often linked to contaminated meat, dairy products, and fresh produce. These outbreaks

emphasize the need for improved food safety practices and effective monitoring systems to

reduce transmission.

2.11 Treatment and Control of Escherichia coli Infections

Escherichia coli infections are commonly treated using a range of antimicrobial agents, depending on

the severity and type of infection. Mild intestinal infections caused by non-invasive strains may resolve

without antibiotic therapy, while severe or systemic infections require prompt antimicrobial treatment.

Commonly used antibiotics include β-lactams, fluoroquinolones, aminoglycosides, and trimethoprim-

sulfamethoxazole.

However, the effectiveness of these antibiotics has been significantly reduced due to the increasing

prevalence of antimicrobial resistance among Escherichia coli strains. Many clinical isolates now exhibit

resistance to multiple classes of antibiotics, making treatment more complicated and less effective

(Dadgostar, 2021). The emergence of extended-spectrum β-lactamase (ESBL)-producing and

carbapenem-resistant E. coli strains is particularly concerning, as these limit the availability of effective

therapeutic options.

The choice of treatment is often guided by antimicrobial susceptibility testing to ensure the use of

effective drugs. Inappropriate or empirical use of antibiotics without proper diagnosis has contributed

greatly to the development and spread of resistant strains (Kumar et al., 2022). Therefore, accurate

diagnosis and targeted therapy are essential in managing E. coli infections.

In addition to pharmacological treatment, several control measures are important in preventing the

spread of Escherichia coli. These include proper sanitation, access to clean water, good personal

hygiene, safe food handling practices, and infection control measures in healthcare settings. Public

health interventions aimed at improving environmental sanitation and reducing contamination play a

critical role in limiting transmission.

Furthermore, antibiotic stewardship programs have been recommended to promote the rational use of

antibiotics and reduce the emergence of resistance. These programs focus on optimizing antibiotic

selection, dosage, and duration of treatment (World Health Organization, 2023). Continuous surveillance

of resistance patterns is also essential for guiding treatment policies and public health strategies.

Due to the growing challenge of antimicrobial resistance, there is increasing interest in alternative

treatment approaches, including the use of medicinal plants with antimicrobial properties. Natural

products such as plant extracts are being investigated as potential sources of new antimicrobial agents

effective against resistant Escherichia coli strains.

2.12 Summary of Literature Gap

While numerous studies have documented the medicinal uses and phytochemical composition of

Vernonia amygdalina, there is still a significant gap in the scientific validation of its activity

against specific clinical isolates of Escherichia coli obtained from local water sources in Nigeria.

Most existing studies focus on standard laboratory strains (e.g., ATCC 25922), which may not

reflect the resistance patterns and virulence factors of clinical isolates obtained from patients or

environmental sources in hospital settings. Clinical isolates often possess plasmid-mediated

resistance genes that could alter the susceptibility to plant extracts. Therefore, the efficacy

observed in this study may not directly translate to clinical efficacy without further testing

against multidrug-resistant clinical isolates. Furthermore, there is limited information on the

specific phytochemicals responsible for the antibacterial activity against E. coli in the Nigerian

context. Many studies report crude extract activity without isolating the active compounds,

making it difficult to standardize dosages or understand the mechanism of action. There is also a

lack of data on the Minimum Bactericidal Concentration (MBC) of Vernonia amygdalina

extracts against E. coli, with most studies stopping at Minimum Inhibitory Concentration (MIC).

Knowing whether the extract is bacteriostatic or bactericidal is crucial for clinical applications.
Additionally, few studies have correlated the phytochemical profile of Vernonia amygdalina

grown in specific Nigerian ecological zones with its antibacterial activity. Environmental factors

such as soil type, altitude, and rainfall can influence the concentration of active constituents like

vernolide and epicatechin.